These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29759779)

  • 1. 16 Years of Cardiac Resynchronization Pacing Among Congenital Heart Disease Patients: Direct Contractility (dP/dt-max) Screening When the Guidelines Do Not Apply.
    Karpawich PP; Bansal N; Samuel S; Sanil Y; Zelin K
    JACC Clin Electrophysiol; 2017 Aug; 3(8):830-841. PubMed ID: 29759779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Non-invasive Studies to Evaluate Resynchronization Pacing Effectiveness in the Young.
    Menon D; Aggarwal S; Kadiu G; Zelin KM; Karpawich PP
    Pediatr Cardiol; 2024 Apr; 45(4):867-875. PubMed ID: 36063175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy for various systemic ventricular morphologies in patients with congenital heart disease.
    Sakaguchi H; Miyazaki A; Yamada O; Kagisaki K; Hoashi T; Ichikawa H; Ohuchi H
    Circ J; 2015; 79(3):649-55. PubMed ID: 25746550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy in adults with congenital heart disease.
    Koyak Z; de Groot JR; Krimly A; Mackay TM; Bouma BJ; Silversides CK; Oechslin EN; Hoke U; van Erven L; Budts W; Van Gelder IC; Mulder BJM; Harris L
    Europace; 2018 Feb; 20(2):315-322. PubMed ID: 28108550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchronization therapy.
    Bogaard MD; Houthuizen P; Bracke FA; Doevendans PA; Prinzen FW; Meine M; van Gelder BM
    Eur J Heart Fail; 2011 Oct; 13(10):1126-32. PubMed ID: 21791536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution.
    Cecchin F; Frangini PA; Brown DW; Fynn-Thompson F; Alexander ME; Triedman JK; Gauvreau K; Walsh EP; Berul CI
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):58-65. PubMed ID: 18775051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and Late Effects of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease.
    Yin Y; Dimopoulos K; Shimada E; Lascelles K; Griffiths S; Wong T; Gatzoulis MA; Babu-Narayan SV; Li W
    J Am Heart Assoc; 2019 Nov; 8(21):e012744. PubMed ID: 31657270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of cardiac resynchronization therapy in congenital heart disease: A meta-analysis and systematic review.
    Tokavanich N; Mongkonsritragoon W; Sattawatthamrong S; Techasatian W; Siranart N; Prasitlumkum N; Navaravong L; Chokesuwattanaskul R
    J Cardiovasc Electrophysiol; 2024 Feb; 35(2):249-257. PubMed ID: 38065836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the response to cardiac resynchronization therapy performed with a new ventricular morphology-based strategy for congenital heart disease.
    Miyazaki A; Negishi J; Hayama Y; Baba S; Matsumura Y; Shima Y; Tsuda E; Sakaguchi H; Hoashi T; Kagisaki K; Noda T; Doi H; Ichikawa H; Ohuchi H
    Heart Vessels; 2019 Aug; 34(8):1340-1350. PubMed ID: 30863899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in patients with congenital heart disease and systemic right ventricle.
    Jacquemart E; Combes N; Duthoit G; Bessière F; Ladouceur M; Iserin L; Laredo M; Bredy C; Maltret A; Di Filippo S; Hascoët S; Pasquié JL; Marijon E; Waldmann V
    Heart Rhythm; 2022 Apr; 19(4):658-666. PubMed ID: 34863963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic Optimization in Cardiac Resynchronization Therapy: Should We Aim for dP/dt
    Zweerink A; Salden OAE; van Everdingen WM; de Roest GJ; van de Ven PM; Cramer MJ; Doevendans PA; van Rossum AC; Vernooy K; Prinzen FW; Meine M; Allaart CP
    JACC Clin Electrophysiol; 2019 Sep; 5(9):1013-1025. PubMed ID: 31537329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of right and left ventricular lead positions during the implantation of cardiac resynchronization therapy defibrillators.
    Stockinger J; Staier K; Schiebeling-Römer J; Keyl C
    Pacing Clin Electrophysiol; 2011 Nov; 34(11):1537-43. PubMed ID: 21797906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy.
    Duckett SG; Ginks M; Shetty AK; Bostock J; Gill JS; Hamid S; Kapetanakis S; Cunliffe E; Razavi R; Carr-White G; Rinaldi CA
    J Am Coll Cardiol; 2011 Sep; 58(11):1128-36. PubMed ID: 21884950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a peak endocardial acceleration-based algorithm to optimize cardiac resynchronization: early clinical results.
    Delnoy PP; Marcelli E; Oudeluttikhuis H; Nicastia D; Renesto F; Cercenelli L; Plicchi G
    Europace; 2008 Jul; 10(7):801-8. PubMed ID: 18492682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcome of Patients With Congenital Heart Disease Undergoing Cardiac Resynchronization Therapy.
    Kubuš P; Rubáčková Popelová J; Kovanda J; Sedláček K; Janoušek J
    J Am Heart Assoc; 2021 Mar; 10(6):e018302. PubMed ID: 33719495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy in congenital heart disease: Results from the German National Register for Congenital Heart Defects.
    Flügge AK; Wasmer K; Orwat S; Abdul-Khaliq H; Helm PC; Bauer U; Baumgartner H; Diller GP;
    Int J Cardiol; 2018 Dec; 273():108-111. PubMed ID: 30297188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2017 Mar; 5(3):204-212. PubMed ID: 28254126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
    Nägele H; Behrens S; Eisermann C
    Europace; 2008 Dec; 10(12):1375-80. PubMed ID: 18776196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum derivative of left ventricular pressure predicts cardiac mortality after cardiac resynchronization therapy.
    Suzuki H; Shimano M; Yoshida Y; Inden Y; Muramatsu T; Tsuji Y; Tsuboi N; Hirayama H; Shibata R; Murohara T
    Clin Cardiol; 2010 Dec; 33(12):E18-23. PubMed ID: 21184541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Myocardial Contractility by SonR Sensor in Patients Undergoing Cardiac Resynchronization Therapy.
    Sacchi S; Perini AP; Attanà P; Grifoni G; Chiostri M; Ricciardi G; Pieragnoli P; Padeletti L
    Pacing Clin Electrophysiol; 2016 Mar; 39(3):268-74. PubMed ID: 26644068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.